The UN World Health Organization says the death toll in the West African Ebola Outbreak is now 1,013 out of 1,848 suspected or confirmed infections in Guinea, Sierra Leone, Liberia, and now in Nigeria which has just confirmed its tenth case.

Liberia announced it will receive the scant few doses of the experimental anti-Ebola drug ZMapp, after the US government put Monrovia in touch with the Mapp pharmaceutical company in San Diego.  There had been complaints that the only three people to be treated with ZMapp were two American aid workers and a Spanish Priest – all three white westerners in an outbreak that’s killed more than a thousand Africans, including an African Nun who worked with the Spanish Priest in Liberia.

“There’s no reason to try this medicine on sick white people and to ignore blacks,” said Marcel Guilavogui, a pharmacist in Conakry, Guinea.  “We understand that it’s a drug that’s being tested for the first time and could have negative side effects.  But we have to try it in blacks too.”

It’s not clear how many more doses actually exist, and Mapp says it is clearing off its shelves for Liberia.  That’s bad news for Guinea, which has requested some, while Sierra Leone has not.  It will take months to synthesize more doses of ZMapp.

In Nigeria, officials confirmed a tenth infection of Ebola in another member of the medical team that treated Patrick Sawyer, a Liberian-American businessman who was symptomatic when he hopped aboard a passenger plane to Lagos.  Sawyer and one of the nurses who treated him died.  Nigeria is monitoring 177 people who came into contact with Sawyer.